glp 1 weight loss drug Patients' Use GLP-1 Drugs for Loss, Benefit Gains Chart: 1 in 8 Americans
Description
Expanded uses in inflammatory bowel disease, neurological diseases, and metabolic dysfunction-associated steatohepatitis (MASH)

Understanding their distinct mechanisms, clinical evidence bases, and how genetic and biomarker data inform personalized treatment selection helps patients and providers make evidence-based decisions

GLP-1 medications are changing how people think about weight loss and how they actually lose weight, driving changes in views about obesity care among health systems and providers and affecting the broader US economy. These drugs hold the potential to help address what continues to be an increasing obesity problem in the US. A 2024 []

This article reviews lactation safety data, medication transfer mechanisms, and what mothers should know before starting tr

The fascinating history of the GLP-1 drugs- Ozempic, Wegovy, and Mounjaro.

Looking for alternatives to Ozempic or Wegovy
